Journal
CHEMICAL SCIENCE
Volume 7, Issue 11, Pages 6779-6785Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c6sc01739h
Keywords
-
Categories
Funding
- JHU Whiting School of Engineering Seed Funds
- American Society for Laser Medicine & Surgery Research Grant
- National Institutes of Health [CA134675, CA184228, CA183031, CA058236, CA151838]
- NATIONAL CANCER INSTITUTE [R01CA134675, U54CA151838, U01CA183031, P50CA058236, R01CA184228] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Precise visualization of tumor margins with characterization of microscopic tumor invasion are unmet needs in prostate oncology that demand approaches with high sensitivity and specificity. To address those needs we report surface-enhanced Raman scattering (SERS) based optical imaging for prostate cancer using a combination of live cell Raman microscopy, optimally engineered SERS tags and a urea-based small-molecule inhibitor of prostate-specific membrane antigen (PSMA) as a targeting moiety. We develop gold nanostar based SERS agents that offer ultrahigh binding affinity to PSMA with nearly four orders of magnitude lower IC50 values in relation to existing clinical imaging agents. This combination enables selective recognition of prostate cancer cells, and facilitates quantitative and photostable Raman measurements. Using Raman microscopy to analyze phenotypically similar prostate cancer cell lines differing only in PSMA expression, we demonstrate facile, site-selective recognition using as low as 20 pM of the SERS agent for imaging, opening the door for spectroscopic detection of prostate and other PSMA-expressing tumors in vivo.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available